MedTrace Logo

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

NCT04900259 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 183

Last updated 2021-10-06

No results posted yet for this study

Summary

In this study, investigators aim to reveal how the COVID-19 pandemic process affects primary bladder cancer presentations, tumor stages and degrees, the time elapsed between diagnosis and intervention, tumor recurrence and progression, which are oncological results.

Conditions

Interventions

BEHAVIORAL

COVID-19 pandemic

Patients diagnosed with primary bladder cancer by transurethral resection in the urology clinic during and before the COVID-19 pandemic will be retrospectively evaluated and compared.

Sponsors & Collaborators

  • Ankara Training and Research Hospital

    lead OTHER

Principal Investigators

  • Ali Kaan Yildiz · Ankara Training and Resarch Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2021-08-01
Completion
2021-08-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04900259 on ClinicalTrials.gov